LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097761 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Teresa Auguet und 9 weiteren Autor:innen. Beteiligte Einrichtung: Grup de Recerca GEMMAIR (AGAUR)-Medicina Aplicada, Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), IISPV, 43005 Tarragona, Sp…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Morbid. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Obesity is a chronic and complex disease, with an increasing incidence worldwide that is associated with metabolic disorders such as type 2 diabetes mellitus (T2DM). Thus, it is important to determine the differences between metabolically healthy obese individuals and those with metabolic disorders. The aim of this study was to perform an untargeted metabolomics assay in women with morbid obesity (MO) compared to a normal weight group, and to differentiate the metabolome of these women with MO who present with T2DM. We carried out a liquid chromatography-mass spectrometry-based untargeted metabolomics assay using serum samples of 209 Caucasian women: 73 with normal weight and 136 with MO, of which 71 had T2DM. First, we found increased levels of choline and acylglycerols and lower levels of bile acids, steroids, ceramides, glycosphingolipids, lysophosphatidylcholines, and lysophosphatidylethanolamines in MO women than in the control group. Then, in MO women with T2DM, we found increased levels of glutamate, propionyl-carnitine, bile acids, ceramides, lysophosphatidylcholine 14:0, phosphatidylinositols and phosphoethanolamines, and lower levels of Phe-Ile/Leu. Thus, we found metabolites with opposite trends of concentration in the two metabolomic analyses. These metabolites could be considered possible new factors of study in the pathogenesis of MO and associated T2DM in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grup de Recerca GEMMAIR (AGAUR)-Medicina Aplicada, Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), IISPV, 43005 Tarragona, Spain.
- Department of Electronic Engineering, Universitat Rovira i Virgili (URV), IISPV, 43007 Tarragona, Spain.
- Servei de Recursos Científics i Tècnics, Universitat Rovira i Virgili (URV), 43007 Tarragona, Spain.
- Unitat de Cirurgia, Facultad de Medicina i Ciències de la Salut, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili (URV), IISPV, 43204 Reus, Spain.
- CIBER de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, 43204 Madrid, Spain.
ORCID-Profile: Laia Bertran, Xavier Correig, Oscar Yanes
Zitieren
APA
Auguet, T., Bertran, L., Capellades, J., Abelló, S., Aguilar, C., Sabench, F., Del Castillo, D., Correig, X., Yanes, O., & Richart, C. (2023). LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097761
Vancouver
Auguet T, Bertran L, Capellades J, Abelló S, Aguilar C, Sabench F, et al. LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097761
BibTeX
@article{Auguet2023,
author = {Auguet, Teresa and Bertran, Laia and Capellades, Jordi and Abelló, Sonia and Aguilar, Carmen and Sabench, Fàtima and Del Castillo, Daniel and Correig, Xavier and Yanes, Oscar and Richart, Cristóbal},
title = {LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097761}
}
EUVIMED